Aclarion, Inc. ACONW

Full chart Compare
Set alert

Price alert · ACONW

All alert types
0.03 USD 0.00 (+11.67%)

Nov 3, 2026, 3:42 PM EST

0.0268 Day range 0.0268
0.0268 52-week range 0.0268
YTD
0.00%
1 year
0.00%
Market cap
11.79K
Revenue (ttm)
53.95K
EPS (ttm)
-6.58
YTD return
0.00%
1-year return
0.00%
Volume
4.09K
Open
0.0268
Previous close
0.024
Day's range
0.0268 – 0.0268
52-week range
0.0268 – 0.0268
Beta
0.40

2Y 0.0000 (0.00%)

No chart data for this range yet.

Key statistics

Enterprise value
0
PEG ratio
0.00
Price / sales
0.00
Price / book
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
-35.70%
Free cash flow
-3.94M
Total cash
1.22M
Total debt
777.09K
Return on equity
-714.18%
Short % of float
0.00%
50-day average
0.00
200-day average
0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

About Aclarion, Inc.

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Sector
Healthcare
Industry
Health Information Services
Country
United States
Website
aclarion.com

News

Your note

Sign in to keep a note on ACONW — it syncs with the Stock Master app.

Institution ownership

ACONW institution ownership
Holder% heldSharesValueReported
Captrust Financial Advisors3.92%78,4001.88KSep 29, 2024
Clear Street LLC2.34%46,7131.12KSep 29, 2024
Citadel Advisors Llc1.83%36,589878Sep 29, 2024
Armistice Capital, LLC1.72%34,375825Sep 29, 2024
UBS Group AG0.00%581Sep 29, 2024